AllyGPO and BioCareSD: Tech-Forward Partners Deliver Unsurpassed Innovation to Community Oncology

Delivering greater value to independent oncology practices with technology-driven specialty drug management.

ORLANDO, Fla., April 30, 2025 /PRNewswire/ -- At the 2025 Community Oncology Alliance (COA) Annual Meeting, AllyGPO® group purchasing organization and BioCareSD® specialty distribution demonstrated how their partnership and strategic technology investments are setting a new standard for delivering innovation and value to community oncology. The collaboration of these two tech-forward organizations is empowering independent oncology practices to enhance their productivity and financial health so they can continue to provide community-based care.

AllyIQ® for Oncology: Transforming specialty drug management in real-world practice

AllyIQ is AllyGPO's comprehensive specialty drug management platform built exclusively for community oncology [https://allygpo.com/allyoncology]. AllyIQ combines role-based workflows with the first, fully smart drug cabinet and powerful business intelligence to help practices optimize their inventory and GPO contract performance. Currently deployed in practices across the U.S., AllyIQ empowers members to dispense confidently and streamline operations to increase the time and resources available for patient care. 

"AllyIQ represents our commitment to bringing true technological innovation to community oncology," said Stuart McMahan, Chief Information Officer at AllyGPO. "We're actively helping practices optimize their drug management and reduce administrative burden. Member adoption of AllyIQ demonstrates the tangible value our investment and collaborative development approach delivers."

BioCareSD agile, sustainable specialty distribution: Combining efficiency and reliability with environmental responsibility

Complementing AllyGPO's efforts, BioCareSD is redefining specialty drug distribution with a modern, nimble delivery platform that outpaces traditional suppliers. The company's sustainable, temperature-controlled packaging – coupled with advanced, tech-enabled logistics – ensures ultra-reliable and efficient delivery of life-saving cancer therapies while maintaining strict quality standards and minimizing environmental impact.

"BioCareSD is dedicated to transforming specialty distribution," added Cory Shouse, Chief Information Officer of BioCare. "Our focus on building a forward-looking system that incorporates sustainable packaging ensures oncology practices get the right drugs at the right time with utmost reliability is precisely what today's community oncology practices need from their SD partner. Integrating drug ordering through AllyIQ from AllyGPO further allows us to deliver exceptional value to our shared customers."

Systems integration with zero technology debt: Delivering a seamless experience with a high level of responsiveness

In addition to integrating with BioCareSD's drug ordering platform, AllyIQ from AllyGPO seamlessly connects to data from practices' existing electronic health record and practice management systems to deliver more accurate, timely analytics about drug utilization, drug economics, and more.

Unlike legacy systems that burden many healthcare organizations, both companies have made strategic investments in building brand new, cloud-native platforms from the ground up with today's community practices in mind. Having infrastructure with zero technology debt allows AllyGPO and BioCareSD unprecedented agility in responding to practice-specific needs and broader market shifts.

"The advantage approach is immediately apparent to our practice partners," continued McMahan. "When a practice requests new functionality or market conditions change, we can implement solutions in days or weeks rather than months or years. This agility is absolutely critical in the fast-evolving oncology space where delays in adapting technology can directly impact patient care."

AllyGPO and BioCareSD: Sharing a vision to empower Community Oncology

The AllyGPO and BioCareSD partnership shares the belief that independent oncology practices deserve better tools, smarter insights, and stronger support to thrive independently, now and into the future.

"Our commitment to innovation is fundamentally improving the way community oncology practices operate," said Brian Ansay, CEO of AllyGPO. "Combined with exceptional service and consultative expertise from a dedicated oncology team, our tech-forward approach brings unprecedented intelligence, efficiency, and value to community oncology. We aren't just keeping up with change — we're leading it."

To learn more about how AllyGPO and BioCareSD's work to support practices at NewOncologyPartner.com.

About AllyGPO

Choose a GPO that puts your independence first. AllyGPO combines new-school technology with old-school hands-on service and dedicated support. AllyIQ is a novel all-in-one platform for GPO administration, business intelligence, and inventory management that includes the first, fully smart oncology drug cabinet. AllyOncology is a GPO supporting the unique needs of the oncology clinic class-of-trade. Together with cutting-edge drug management, timely, accurate analytics, and expert guidance, AllyGPO helps practices improve efficiency, enhance financial performance, and keep community oncology care viable and growing. Learn more at www.AllyGPO.com.

About BioCareSD

BioCareSD, a BioCare company, is a national specialty distributor with more than 40 years of experience delivering life-saving specialty therapies. With a commitment to redefining specialty distribution, BioCareSD focuses on trust, transparency, and operational excellence. The company provides a high-touch, personalized service through a dedicated support team and 24/7/365 customer care. Its expanding portfolio and distribution model support its partners in their mission to save lives. For more information, visit www.biocaresd.com.

Media Contact:
Dara Shulman
866-255-9476
[email protected]

SOURCE AllyGPO|BioCareSD